About Lexogen

Lexogen is an ambitious biotech start-up with unique proprietary expression profiling technologies that enable detailed profiling of the complete transcriptome as well as individual full length RNAs of interest.

Lexogen was founded in 2007 and is funded by both private capital and public funds. Lexogen is supported by the Austrian Research Promotion Agency FFG, the Austria Wirtschaftsservice AWS, INiTS and the Wirtschaftsagentur Wien.

Lexogen employs 25 scientists and staff and is based in Vienna, Austria.